CLINICAL TRIALS PROFILE FOR LOSARTAN POTASSIUM

All Clinical Trials for LOSARTAN POTASSIUM

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00090259 ↗	Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2001-12-19	This is a multicenter study to evaluate potential decrease in hospitalization events and time between events and increasing longevity in patients with symptomatic congestive heart failure and intolerant of first-line medication for heart failure. This study will evaluate if higher doses of the investigational drug given daily will be superior to the lower dose of the same investigational drug given daily.
NCT00140907 ↗	ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)	Completed	Merck Sharp & Dohme Corp.	Phase 4	2000-03-14	To demonstrate that losartan (+ conventional therapy) compared to placebo (+ conventional therapy) will reduce the number of RT patients who experience histological lesions of chronic allograft nephropathy
NCT00140985 ↗	Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)	Completed	Merck Sharp & Dohme Corp.	Phase 4	2000-02-01	Antiproteinuric Efficacy of Losartan Potassium in Patients with Non-Diabetic Proteinuric Renal Diseases.
NCT00157963 ↗	Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)	Completed	Merck Sharp & Dohme Corp.	Phase 4	2005-02-05	An efficacy and safety study of hydrochlorothiazide (+) losartan potassium compared to amlodipine at week 12 in Korean patients with essential hypertension
NCT00185094 ↗	A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin	Completed	Daiichi Sankyo Inc.	Phase 4	2004-02-01	To examine the effect of three different blood pressure medications on the insulin sensitivity in overweight patients with high blood pressure.
NCT00185094 ↗	A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin	Completed	Daiichi Sankyo, Inc.	Phase 4	2004-02-01	To examine the effect of three different blood pressure medications on the insulin sensitivity in overweight patients with high blood pressure.

Clinical Trial Conditions for LOSARTAN POTASSIUM

Condition Name

Condition Name for LOSARTAN POTASSIUM
Intervention	Trials
Hypertension	33
Healthy	8
Essential Hypertension	4
Proteinuria	3

Condition MeSH

Condition MeSH for LOSARTAN POTASSIUM
Intervention	Trials
Hypertension	36
Essential Hypertension	8
Kidney Diseases	8
Fibrosis	4

Clinical Trial Locations for LOSARTAN POTASSIUM

Trials by Country

Trials by Country for LOSARTAN POTASSIUM
Location	Trials
United States	117
China	23
India	4
Brazil	3
Italy	3

Trials by US State

Trials by US State for LOSARTAN POTASSIUM
Location	Trials
California	11
Texas	10
Ohio	7
North Carolina	5
New York	5

Clinical Trial Progress for LOSARTAN POTASSIUM

Clinical Trial Phase

Clinical Trial Phase for LOSARTAN POTASSIUM
Clinical Trial Phase	Trials
Phase 4	18
Phase 3	18
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for LOSARTAN POTASSIUM
Clinical Trial Phase	Trials
Completed	59
Recruiting	9
Terminated	7

Clinical Trial Sponsors for LOSARTAN POTASSIUM

Sponsor Name

Sponsor Name for LOSARTAN POTASSIUM
Sponsor	Trials
Merck Sharp & Dohme Corp.	21
Steadman Philippon Research Institute	4
Roxane Laboratories	4

Sponsor Type

Sponsor Type for LOSARTAN POTASSIUM
Sponsor	Trials
Other	56
Industry	49
NIH	11